1) Darglitazone
达格列酮
2) gliquidone
格列喹酮
1.
Preparation and Dissolution Rate of Gliquidone Solid Dispersion;
格列喹酮固体分散体的制备及溶出度测定
2.
Prescription and Process of Dispersible Gliquidone Tablets;
格列喹酮分散片处方工艺研究
3.
Preparation of gliquidone tablet and determination of its dissolution;
格列喹酮片的处方考查及溶出度测定
3) rosiglitazone
罗格列酮
1.
Effect of rosiglitazone on pulmonary inflammation in streptozocin-induced diabetic rats;
罗格列酮对糖尿病大鼠肺炎性病变的影响
2.
Experimental study on the protective effects of rosiglitazone on aortic endothelial cells of spontaneously type 2 diabetic rats;
罗格列酮对自发性2型糖尿病大鼠主动脉内皮细胞保护作用的实验研究
3.
The anti-hypertensive effect of insulin sensitizer rosiglitazone in two sorts of hypertensive rat;
罗格列酮对2种高血压大鼠的降压作用及机制
4) troglitazone
曲格列酮
1.
Influence of troglitazone on proliferation of human liver cancer cell line HepG2 in vitro and on β-catenin signaling pathway;
曲格列酮体外对肝癌细胞HepG2生长及β-catenin信号通路的影响
2.
Troglitazone induces gastric cancer cell line MKN45 apoptosis;
曲格列酮诱导胃癌MKN45细胞株凋亡
3.
Effects of troglitazone on proliferation and differentiation of human preadipocytes;
曲格列酮对人前脂肪细胞增殖和分化的影响
5) pioglitazone
吡格列酮
1.
Pioglitazone Combined Insulin for Type 2 Diabetes Mellitus;
吡格列酮与胰岛素联合治疗2型糖尿病疗效观察
2.
Effects of insulin and pioglitazone on proliferation,apoptosis and NO secretion of endothelial progenitor cells;
吡格列酮和胰岛素对内皮祖细胞增殖和凋亡及分泌一氧化氮的影响
3.
Relationship between nonalcoholic fatty liver disease and levels of serum adiponectin and tumor necrosis factor-α in obese rats and pioglitazone intervention;
肥胖大鼠非酒精性脂肪肝与血清脂联素和肿瘤坏死因子α的关系及吡格列酮干预
6) pioglitazone
匹格列酮
1.
Effect of pioglitazone on the proliferation and differentiation of orbit preadipocytes in healthy adults and patients with thyroid-associated ophthalmopathy;
匹格列酮对正常人和甲状腺相关眼病患者眼眶前脂肪细胞增殖和分化的影响
2.
Effects of Pioglitazone on the expression of tumor necrosis factor-α(TNF-α)in the renal of diabetic rats;
匹格列酮对糖尿病大鼠TNF-α表达的影响
3.
Effect of Pioglitazone on Inflammatory Markers in Type 2 Diabetes Mellitus;
匹格列酮对2型糖尿病炎症标志物的影响研究
补充资料:格列喹酮
分子式:C27H33N3O6S
分子量:暂无
CAS号:33342-05-1
性质:暂无
制备方法:暂无
用途:降血糖药,用于非胰岛素依赖型糖尿病药。
分子量:暂无
CAS号:33342-05-1
性质:暂无
制备方法:暂无
用途:降血糖药,用于非胰岛素依赖型糖尿病药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条